MARC Record from Library of Congress

LEADER: 01736cam a2200325 a 4500
001 2012009446
003 DLC
005 20141211085123.0
008 120305s2012 flua b 001 0 eng
010 $a 2012009446
020 $a9781439845677 (hardback : alk. paper)
035 $a(DNLM)101579512
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRA1238$b.G333 2012
060 10 $aQV 771
082 00 $a615.7/04$223
100 1 $aGad, Shayne C.,$d1948-
245 10 $aSafety pharmacology in pharmaceutical development :$bapproval and post marketing surveillance /$cShayne C. Gad.
250 $a2nd ed.
260 $aBoca Raton, FL :$bCRC Press,$cc2012.
300 $axv, 197 p. :$bill. ;$c24 cm.
500 $aRev. ed. of: Safety pharmacology in pharmaceutical development and approval. c2004.
504 $aIncludes bibliographical references and index.
520 $a"This book covers the regulatory required evaluation and study of the potentially adverse pharmacological effects of new drugs, from the general regulatory requirements to the specific studies that must be done and how they are performed and interpreted. Based on more than 30 years of direct experience, the author describes tricks and practical insights for making studies work and understanding why they don't. The second edition includes current regulations (US FDA and international especially Europe and Japan) and updated test methods, interpretation, and science"--Provided by publisher.
650 12 $aDrug Evaluation, Preclinical.
650 22 $aDrug Approval.
650 22 $aProduct Surveillance, Postmarketing.
650 22 $aToxicity Tests.
700 1 $aGad, Shayne C.,$d1948-$tSafety pharmacology in pharmaceutical development and approval.